Viatris – Global Leader in Regulated Medicines & Accessible Healthcare Solutions

Viatris is a trusted global pharmaceutical and healthcare brand recognized for delivering clinically reliable, regulated medicines that support patient well-being across a broad range of therapeutic needs. Formed through the integration of modern research capabilities and extensive industry expertise, Viatris is committed to providing safe, affordable, and accessible treatment options that strengthen healthcare systems worldwide. Patients rely on Viatris medicines for chronic disease management, preventive care, and acute treatment support guided by strict medical standards.

Extensive Portfolio of High-Quality Medicines

The Viatris product portfolio includes a wide range of prescription medicines, generic formulations, complex therapies, biologics, biosimilars, vaccines, and essential consumer healthcare products. These solutions support major medical specialties and diverse patient needs.

Key therapeutic areas include:

• Cardiology and cardiovascular health
• Oncology support therapies
• Endocrinology and metabolic care
• Neurology
• Allergy and immunology
• Women’s health
• Infectious disease management
• Respiratory disorders
• Dermatology
• Gastrointestinal care

Commitment to Safety, Quality & Regulatory Excellence

Safe treatment depends on medicines that deliver reproducible quality, accurate dosing, and validated clinical effectiveness. Viatris upholds these expectations through comprehensive quality systems, including laboratory evaluation, stability testing, ingredient authentication, and manufacturing control processes.

• Good Manufacturing Practices (GMP) compliance
• Quality frameworks aligned with leading health authorities
• Rigorous testing for potency, purity, and consistency
• Ongoing regulatory oversight and validation

These measures help protect patients from unsafe or substandard treatment alternatives by ensuring every product meets recognized international benchmarks.

Affordable Medicines Supporting Long-Term Treatment

Affordability is a core focus for Viatris. Many patients managing long-term or complex conditions rely on cost-effective medicines to maintain treatment continuity. Viatris supports better health outcomes by making safe, clinically proven therapies more accessible—particularly for individuals living with conditions such as hypertension, diabetes, asthma, autoimmune disorders, and cardiovascular disease.

Leading Provider of Biosimilars

Viatris is globally recognized as a major provider of biosimilars—advanced medicines designed to deliver clinically equivalent performance to high-cost biologic therapies. These treatments are essential in oncology, inflammatory disease management, and long-term autoimmune care.

• Scientifically validated therapeutic equivalence
• Enhanced affordability for essential biologic-based treatments
• Broader patient access to specialty care

Through biosimilar innovation, Viatris expands access to advanced therapies that previously posed significant financial challenges for patients.

Transparent Pharmaceutical Communication

Clear pharmaceutical communication helps patients and healthcare providers use medications responsibly and effectively. Every Viatris product includes detailed treatment information, such as:

• Accurate dosage instructions
• Clinical indications and usage guidance
• Storage requirements
• Contraindications and safety warnings

These patient-focused details reinforce safe medication practices and professional supervision.

Secure & Ethical Distribution Systems

To safeguard patient well-being, Viatris maintains a controlled distribution network that operates exclusively through licensed pharmacies, hospitals, and regulated healthcare providers. This ensures that only authentic, approved medicines reach patients, protecting against counterfeit or unsafe alternatives.

A Global Vision for Healthcare Equality

Supported by advanced scientific infrastructure, international expertise, and a strong commitment to healthcare equality, Viatris continues to serve as a trusted global pharmaceutical partner. Its focus on quality, consistency, affordability, and regulatory compliance strengthens healthcare systems and provides reliable access to medically validated treatment options.

FAQs – Viatris

What does Viatris specialize in?

Viatris specializes in delivering regulated medicines, including prescription drugs, generics, biosimilars, and consumer healthcare products across major therapeutic categories.

Are Viatris medicines regulated?

Yes. All Viatris products undergo strict quality testing and are manufactured in compliance with internationally recognized health authority standards and GMP protocols.

Does Viatris focus on affordability?

Absolutely. Viatris develops cost-effective medicines to support patients managing chronic or long-term medical conditions, improving treatment accessibility.

What therapeutic areas does Viatris cover?

Viatris supports cardiology, oncology, endocrinology, neurology, respiratory care, dermatology, gastrointestinal health, and more through its extensive portfolio.

What role does Viatris play in biosimilar development?

Viatris is a leading global provider of biosimilars, offering clinically equivalent alternatives to high-cost biologics used in oncology, autoimmune care, and inflammatory disease management.

How does Viatris protect patients from counterfeit medicine?

Viatris distributes products exclusively through licensed pharmacies and regulated healthcare channels to ensure only authentic, approved medicines reach patients safely.